ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,2,Intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
4,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
4,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
5,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
6,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
7,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
8,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
8,2,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
9,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
10,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
11,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
12,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
13,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
14,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
16,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
17,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
18,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
18,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,3,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
19,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
21,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
22,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
22,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
22,3,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
22,4,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
23,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
24,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
25,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
25,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Congenital joint malformation,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
26,2,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
26,3,Congenital musculoskeletal disorder of skull,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
26,4,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
27,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
28,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
29,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
29,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
29,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
30,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
31,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
32,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,2,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
34,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
35,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
36,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,2,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
37,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
38,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
38,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
39,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
39,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
39,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
40,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
41,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
41,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
41,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
42,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
42,2,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
43,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
44,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
45,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
46,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
46,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
46,3,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
46,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
47,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
47,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
47,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
48,1,Colonic haematoma,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
48,2,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
48,3,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
49,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
50,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
51,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
52,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
52,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
52,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
52,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
53,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
53,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
53,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
53,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
54,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
54,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
54,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
54,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
55,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
55,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
55,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
56,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
56,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
57,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
58,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
58,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
58,3,Headache,Headaches NEC,Headaches,Nerv,N
58,4,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
58,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
58,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
59,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
60,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
61,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
62,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,2,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
63,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
63,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
63,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
64,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
64,2,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
64,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
65,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
66,1,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
67,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
68,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
69,1,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
69,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
70,1,Headache,Headaches NEC,Headaches,Nerv,N
71,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
71,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
71,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
71,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
71,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
72,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
72,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
72,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
72,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
72,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
72,6,Inguinal hernia repair,Hernia repairs,Gastrointestinal therapeutic procedures,Surg,N
72,7,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
72,8,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
72,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
72,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
73,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
73,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
73,3,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
73,4,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
74,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
75,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
75,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
75,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
76,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
77,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
77,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
77,3,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
77,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
78,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
78,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
78,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
78,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
78,6,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
78,7,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
78,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
78,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
78,10,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
78,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,13,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,14,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
79,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
80,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
81,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
81,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
82,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
83,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
83,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
84,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
85,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
86,1,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,Y
